Expertise in
17
conditions

Dr. Mark Nestor

Dermatology
Office
2925 Aventura Blvd Ste 205, 
Miami, FL 
Offers Telehealth

Expertise in
17
conditions
Office
2925 Aventura Blvd Ste 205, 
Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Nestor is a Dermatologist in Miami, Florida. Dr. Nestor is highly rated in 17 conditions, according to our data. His top areas of expertise are Keloids, Sunburn, Actinic Keratosis, Bowen's Disease, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 86 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Office
2925 Aventura Blvd Ste 205, Miami, FL 33180
Call: 305-933-6716

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
Enrollment Status: Active_not_recruiting
Publish Date: May 13, 2025
Intervention Type: Biological, Other
Study Drug: KB301
Study Phase: Phase 1
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
Enrollment Status: Completed
Publish Date: March 19, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
A Phase 1 Study to Evaluate the Safety and Tolerability of Subcutaneous Injection of STP705 in Adult Subjects Undergoing Abdominoplasty
A Phase 1 Study to Evaluate the Safety and Tolerability of Subcutaneous Injection of STP705 in Adult Subjects Undergoing Abdominoplasty
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug
Study Phase: Phase 1
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Localized Injection of STP705 in Adult Patients With Basal Cell Carcinoma
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Localized Injection of STP705 in Adult Patients With Basal Cell Carcinoma
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug
Study Drug: STP705 TGF-Beta1 Cox2 mRNA siRNA Oligonucleotides
Study Phase: Phase 2
An Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD), Safety, and Tolerability of Microneedle Arrays Containing Doxorubicin (D-MNA) in Participants With Basal Cell Carcinoma (BCC)
An Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD), Safety, and Tolerability of Microneedle Arrays Containing Doxorubicin (D-MNA) in Participants With Basal Cell Carcinoma (BCC)
Enrollment Status: Terminated
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: Microneedle arrays containing doxorubicin
Study Phase: Phase 1
A Double-Blind, Pilot Study to Evaluate the Efficacy and Safety of Topical AFX 5931 in the Treatment of Mild to Moderate Hand Dermatitis
A Double-Blind, Pilot Study to Evaluate the Efficacy and Safety of Topical AFX 5931 in the Treatment of Mild to Moderate Hand Dermatitis
Enrollment Status: Completed
Publish Date: January 04, 2023
Intervention Type: Drug
Study Phase: Phase 4
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
An Open Label, Dose Escalation Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Prospective, Randomized, Double-blind, Placebo Controlled and Comparative Clinical Study Evaluating Scar-management Modalities for Simple and Effective Management of Hyperproliferative (Hypertrophic) Scars and Keloids
A Prospective, Randomized, Double-blind, Placebo Controlled and Comparative Clinical Study Evaluating Scar-management Modalities for Simple and Effective Management of Hyperproliferative (Hypertrophic) Scars and Keloids
Enrollment Status: Completed
Publish Date: March 21, 2022
Intervention Type: Other
Study Phase: Not Applicable
Randomized, Double-blind, Comparative Pilot Study Investigating the Safety and Clinical Efficacy of Applying a Restorative Wound Care Cream Together With Petrolatum on Anatomically Similar Surgical Excisions
Randomized, Double-blind, Comparative Pilot Study Investigating the Safety and Clinical Efficacy of Applying a Restorative Wound Care Cream Together With Petrolatum on Anatomically Similar Surgical Excisions
Enrollment Status: Completed
Publish Date: March 21, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

86 Total Publications

RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity.
RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity.
Journal: Toxins
Published: August 27, 2025
View All 86 Publications
Similar Doctors
Expertise in
29
conditions
Dr. Antonella Tosti
Dermatology
Expertise in
29
conditions
Dr. Antonella Tosti
Dermatology

University Of Miami

1295 Nw 14th St, 
Miami, FL 
 (12.8 miles away)
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

Antonella Tosti is a Dermatologist in Miami, Florida. Dr. Tosti is highly rated in 29 conditions, according to our data. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Alopecia Areata, Splinter Hemorrhages, and Ringworm. Dr. Tosti is currently accepting new patients.

Expertise in
20
conditions
Dr. Gil Yosipovitch
Dermatology
Expertise in
20
conditions
Dr. Gil Yosipovitch
Dermatology

University Of Miami

1828 Ponce De Leon Blvd, 
Coral Gables, FL 
 (16.0 miles away)
305-585-6913
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

Gil Yosipovitch is a Dermatologist in Coral Gables, Florida. Dr. Yosipovitch is highly rated in 20 conditions, according to our data. His top areas of expertise are Prurigo Nodularis, Atopic Dermatitis, Stasis Dermatitis and Ulcers, and Lichen Simplex Chronicus. Dr. Yosipovitch is currently accepting new patients.

Expertise in
16
conditions
Dr. Mariya I. Miteva
Dermatology
Expertise in
16
conditions
Dr. Mariya I. Miteva
Dermatology

University Of Miami

1150 Nw 14th St, 410 Pac, 
Miami, FL 
 (12.8 miles away)
305-243-3100
Languages Spoken:
English, Bulgarian, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Mariya Miteva is a Dermatologist in Miami, Florida. Dr. Miteva is highly rated in 16 conditions, according to our data. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Graham-Little-Piccardi-Lassueur Syndrome, Dissecting Cellulitis of the Scalp, and Discoid Lupus Erythematosus (DLE). Dr. Miteva is currently accepting new patients.

VIEW MORE Dermatologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nestor's expertise for a condition
ConditionClose
    • Distinguished
    • Actinic Keratosis
      Dr. Nestor is
      Distinguished
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Keloids
      Dr. Nestor is
      Distinguished
      . Learn about Keloids.
      See more Keloids experts
    • Sunburn
      Dr. Nestor is
      Distinguished
      . Learn about Sunburn.
      See more Sunburn experts
    • Advanced
    • Acne
      Dr. Nestor is
      Advanced
      . Learn about Acne.
      See more Acne experts
    • Basal Cell Skin Cancer
      Dr. Nestor is
      Advanced
      . Learn about Basal Cell Skin Cancer.
      See more Basal Cell Skin Cancer experts
    • Bowen's Disease
      Dr. Nestor is
      Advanced
      . Learn about Bowen's Disease.
      See more Bowen's Disease experts
    • Erythroderma
      Dr. Nestor is
      Advanced
      . Learn about Erythroderma.
      See more Erythroderma experts
    • Familial Atypical Multiple Mole Melanoma Syndrome
      Dr. Nestor is
      Advanced
      . Learn about Familial Atypical Multiple Mole Melanoma Syndrome.
      See more Familial Atypical Multiple Mole Melanoma Syndrome experts
    • Giant Congenital Melanocytic Nevus
      Dr. Nestor is
      Advanced
      . Learn about Giant Congenital Melanocytic Nevus.
      See more Giant Congenital Melanocytic Nevus experts
    View All 14 Advanced Conditions
    • Experienced
    • Alopecia Areata
      Dr. Nestor is
      Experienced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Athlete's Foot
      Dr. Nestor is
      Experienced
      . Learn about Athlete's Foot.
      See more Athlete's Foot experts
    • Autoerythrocyte Sensitivity
      Dr. Nestor is
      Experienced
      . Learn about Autoerythrocyte Sensitivity.
      See more Autoerythrocyte Sensitivity experts
    • Autosomal Recessive Hypotrichosis
      Dr. Nestor is
      Experienced
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Balanitis
      Dr. Nestor is
      Experienced
      . Learn about Balanitis.
      See more Balanitis experts
    • Boils
      Dr. Nestor is
      Experienced
      . Learn about Boils.
      See more Boils experts
    View All 59 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Dermatologists Miami, FL
    3. Dr. Mark Nestor
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.